Single cell analysis enable to unlock the mystery in gene expression profiles between individual cells. Currently, these technqniues are commonly used in research applications such as in cancer research, immunological research, neurological research, and stem cells research to help in diagnostics. These research is being done at academic & research institutes, biotechnology and biopharmaceutical companies, and cell banks and IVF centers.

[b]Explore Report with Detailed TOC at:[/b] https://www.psmarketresearch.com/market-analysis/single-cell-analysis-market

Among the different type of single-cell analysis consumable products, the reagents segment is expected to witness the fastest growth during the forecast period. Among the different type of technique, the next-Generation Sequencing (NGS) segment is expected to witness the fastest growth during the forecast period. And among the various end users, the hospitals and diagnostic laboratories segment accounted for the largest share in the global market in 2015.

Factors such as growing geriatric population, technological advancements in single-cell analysis products, high prevalence of infectious diseases are the important drivers for this market. However, high cost of single-cell analysis products, intellectual property rights issues restrict innovations in assay kits are the key restraints in the growth of the global single-cell analysis market worldwide. Integration of microfluidics in single-cell analysis and encouraging stem cell research are providing opportunities for the market players to manufacture such type of single-cell analysis instruments.

[b]Explore Report Sample at:[/b] https://www.psmarketresearch.com/market-analysis/single-cell-analysis-market/report-sample

Some of the key companies operating in the global single-cell analysis market include Thermo Fisher Scientific Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Nanostring technologies, Agilent Technologies, Fluidigm Corporation.